Femasys Inc. (FEMY) - Year-over-year earnings per share growth for the last twelve months

Brandmark of Femasys Corp (FEMY)

The quarterly EPS chart for Femasys Inc. (FEMY) demonstrates the development of a women's health ecosystem, where unique therapy methods create high clinic loyalty to the vendor. System assembly in the US guarantees stable supplies without logistical disruptions. The value of 58.30 indicates the current profit level, while management focuses on the imminent receipt of regulatory clearances for new devices.

FEMY: Femasys Year-over-year earnings per share growth rate for the last twelve months 07/04/2022 - 11/14/2026

FEMY (femasys.com): analytical breakdowns and indicator data

- market value and analyst target forecast:
Price Chart Femasys Inc.|FEMY - Broker Consensus Forecast
- market capitalization indicators:
Market Value Femasys Inc|FEMY - Company Buyout Price
- book capitalization data:
Accounting Value per Share Femasys|FEMY - Total Net Assets|Market Value to Book Value Ratio femasys.com|FEMY - Aggregate Asset Value
- debt level and financial liquidity data:
Total Debt to Equity Ratio Femasys Inc.|FEMY - Long-Term Debt to Capital|Short-Term Debt to Equity Femasys Inc|FEMY - Company Total Debt|Debts to Book Capitalization Femasys Corp|FEMY - Long-Term Debt|Company Short-Term Debt Femasys|Quick Liquidity Indicator femasys.com
- earnings and valuation multiples information:
FEMY - Profit After Payment of Taxes|Expected Profit Femasys Inc.|FEMY - Business Payback Period|Forward P/E Multiple Femasys Corp|FEMY - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple Femasys Corp|FEMY - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Femasys|FEMY - Net earnings per share for the last 12 months|Quarterly EPS earnings growth femasys.com|FEMY - Earnings growth in current year|Net earnings per share growth forecast for next year Femasys Inc.
- sales and revenue indicators:
FEMY - Company Gross Revenue|Company Future Sales Volume femasys.com|FEMY - Price to Sales|Price-to-Projected Revenue Ratio Femasys Inc
Basic company analysis:femasys.com - FEMY
Finished products of Femasys Inc.

Leveraging patent protection for non-surgical contraception methods, Femasys Inc. effectively maintains its market share, transforming its technological advantage into a stable cash flow. This quarterly earnings per share metric calculates the daily growth rate of net yield, allowing investors to assess the real efficiency of business capitalization and avoid overpaying for the asset by analyzing the trend on this chart.

Analysis of competing companies

Intuitive Surgical (ISRG) - Year-over-year earnings per share growth for the last twelve months|DHR - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BDX|STE (steris.com) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months West Pharmaceutical Services, Inc. (WST)|BAX (Baxter Corp) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Masimo Personal Health MASI|Year-over-year earnings per one share growth for the last 12 months STVN|TFX - Year-over-year earnings per share growth for the last twelve months|MMSI - Quarterly EPS earnings growth|Envista Holdings Corporation (NVST) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months ICU Medical|XRAY (dentsplysirona.com) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months LeMaitre Corp LMAT|Year-over-year earnings per share growth for the last twelve months AtriCure (ATRC)|STAAR Surgical - Year-over-year earnings per share growth for the last 12 months|Chromadex Corp - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ZIMV (ZimVie Inc)|ANGO - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Cerus Corp CERS|TKNO: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months monogramorthopedics.com|STSS (sharpstechnology.com) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months INFU (InfuSystem Holdings)|Quarterly EPS earnings growth UTMD|KRMD (KORU Medical Systems Inc.) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Nyxoah SA NYXH|Year-over-year earnings per one share growth for the last 12 months MBOT|Pro-Dex Corp - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Zentek Ltd|ELUT: Quarterly EPS earnings growth|MLSS: Year-over-year earnings per share growth rate for the last twelve months|Year-over-year net earnings per share growth for the last 12 months NXGL|Quarterly EPS earnings growth Retractable Technologies|Year-over-year net earnings per share growth for the last 12 months HBIO (Harvard Bioscience)|MHUA - Earnings per share growth in annualized terms for the last twelve months|Predictive Oncology Corp - Year-over-year net earnings per share growth for the last 12 months|CJMB - Year-over-year net earnings per share growth for the last 12 months|ATRI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months NeuroMetrix NURO